| Literature DB >> 30007463 |
Patrizia Bonadonna1, Luigi Scaffidi2.
Abstract
Up to 7% of adult patients with Hymenoptera venom allergy may suffer from a clonal mast cell disease. Patients with clonal mast cell disease and Hymenoptera venom anaphylaxis are commonly males, without skin lesions, and anaphylaxis is characterized by hypotension and syncope in the absence of urticaria and angioedema. A normal value of tryptase does not exclude a mastocytosis. The diagnosis of a mast cell disease leads to several therapeutic consequences concerning the treatment of Hymenoptera venom allergy as matter of fact these patients have to undergo long-life venom immunotherapy, to prevent further, potentially fatal severe reactions.Entities:
Keywords: Anaphylaxis; Clonal mast cell disease; Hymenoptera venom allergy; Monoclonal mast cell activation syndrome; Systemic mastocytosis; Tryptase
Mesh:
Substances:
Year: 2018 PMID: 30007463 DOI: 10.1016/j.iac.2018.04.010
Source DB: PubMed Journal: Immunol Allergy Clin North Am ISSN: 0889-8561 Impact factor: 3.479